Hua Yu

Dr. Hua Yu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
GBGang Bai
Gang Bai
ZFZhichao Fan
Zhichao Fan
XZXiaoxin Zhao
Xiaoxin Zhao
YDYan Dong
Yan Dong
CTCongcong Tan
Congcong Tan
HYHua Yu
Hua Yu

13 June 2025 in Medicine
Verified
Journal Article
Open access
QHQiuhan Heng
Qiuhan Heng
YLYing Leng
Ying Leng
GBGang Bai
Gang Bai
HYHua Yu
Hua Yu
Distant-metastatic hepatocellular carcinoma (DM-HCC) represents the terminal stage of liver cancer, characterized by the spread of cancer cells from the primary tumor site in the liver to distant organs, such as the lungs, bones, or lymph nodes. This study aims to develop a predictive model for assessing cancer-specific survival (CSS) in patients with DM-HCC. We extracted data from the surveillance, epidemiology, and end results (SEER) database for 651 patients initially diagnosed with DM-HCC between 2010 and 2017. The patients were randomly allocated to the training and validation cohorts at a 7:3 ratio. Cox regression analysis was used to identify predictors of CSS. The nomogram was validated using concordance index (C-index), receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis. Multivariate Cox regression analysis showed that alpha-fetoprotein (AFP) expression, grade, T stage, lung metastasis, surgery, radiation, and chemotherapy were independent predictors of CSS. A predictive model was established based on these factors, and a nomogram method was used for visualization. The C-index of the nomogram were 0.721 and 0.726 in the training and validation sets, respectively. In the training set, the time-dependent area under the curve (AUC) values were 0.796, 0.797, and 0.766 at 4, 8, and 12 months, respectively. In the validation set, time-dependent AUC values were 0.767, 0.771, and 0.834 at 4, 8, and 12 months, respectively. Calibration curves indicated good consistency between the actual observed values and the nomogram predictions for CSS, while decision curve analysis demonstrated that the nomogram has good clinical application value. Simultaneously, a risk classification system was established, perfectly categorizing DM-HCC patients into 2 risk groups: low- and high-risk groups. We developed a nomogram with high accuracy for predicting the prognosis of patients with DM-HCC, which is important for enhancing the survival and prognosis of this patient population.

16 October 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LYLi Ye
Li Ye
ZFZhichao Fan
Zhichao Fan
XZXin Zhang
Xin Zhang
YCYanrong Chen
Yanrong Chen
JZJie Zhang
Jie Zhang
HYHua Yu
Hua Yu
Liver disease is a serious global health challenge, with high morbidity and mortality that put significant socioeconomic stress on society. Despite therapeutic advances, current regimens have been limited by rapid drug resistance and insufficient targeting accuracy, and there is an urgent need for new methods. Plant-derived exosome-like nanoparticles (PELNs) are a promising natural nanotherapeutic platform due to their low immunogenicity, high biocompatibility, and prolonged stability in biological fluids. We review the biological sources, basic properties, and key preparative techniques for PELNs and characterize their mechanisms of action and therapeutic use in common liver diseases. We analyze their multiple-target hepatoprotective mechanisms including liver-specific targeting pathways and reducing critical inflammatory and antioxidant cascades. We summarize the therapeutic performance of different PELNs in major hepatic models including hepatocellular carcinoma, hepatic fibrosis, alcohol-related liver disease, and acute liver failure, highlighting key plant sources, primary biological effects, and precise molecular pathways. Moreover, one of the major methodological contributions of this work is the proposal of a new recommended extraction framework based on differential and density gradient centrifugation, optimized specifically for different plant tissue types (leaves, roots/stems, and fruits) to minimize technical heterogeneity. Finally, we discuss the major challenges that impede clinical translation of these nanovesicles, including incompletely elucidated mechanisms, imperfect manufacturing practices, and inadequate safety evaluation mechanisms, pointing to important, useful directions for future applications in hepatology.